EKF Diagnostics Holdings plc (AIM:EKF)
London · Delayed Price · Currency is GBP · Price in GBX 24.40
-1.45 (-5.61%)
Sep 25, 2026, 4:35 PM GMT
EKF Diagnostics Holdings Market Cap
EKF Diagnostics Holdings has a market cap or net worth of 110.7 million as of September 25, 2026. Its market cap has decreased by -17.28% in one year.
Market Cap
110.70M
Enterprise Value
97.42M
Revenue
51.35M
Ranking
n/a
PE Ratio
45.41
Stock Price
24.40
ChartMarket Cap Chart
Since June 30, 2003, EKF Diagnostics Holdings's market cap has increased from 2.27M to 110.70M, an increase of 4,769.14%. That is a compound annual growth rate of 18.19%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 24, 2026 | 110.70M | -3.38% |
| Dec 31, 2025 | 114.57M | -6.48% |
| Dec 31, 2024 | 122.51M | -14.69% |
| Dec 29, 2023 | 143.61M | -36.87% |
| Dec 30, 2022 | 227.47M | -34.63% |
| Dec 31, 2021 | 347.95M | 6.58% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Smith & Nephew | 8.47B |
| NIOX Group | 284.51M |
| AOTI, Inc. | 138.27M |
| Creo Medical Group | 55.02M |
| RUA Life Sciences | 17.38M |
| Inspiration Healthcare Group | 16.59M |
| Proteome Sciences | 5.24M |
| Surgical Innovations Group | 3.96M |